|
|
|
Volumn 36, Issue 1-4, 1997, Pages 356-358
|
|
Efficacy of prevention of thromboembolic complications with LMW-heparin in experiment.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR 10A;
FIBRINOGEN;
FIBRINOLYTIC AGENT;
NADROPARIN;
PROTHROMBIN;
ANIMAL;
ARTICLE;
DISEASE MODEL;
DOG;
DRUG ANTAGONISM;
DRUG EFFECT;
FOLLOW UP;
HIP ARTHROPLASTY;
LUNG EMBOLISM;
PARTIAL THROMBOPLASTIN TIME;
PREMEDICATION;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
THROMBOPHLEBITIS;
ANIMALS;
ANTICOAGULANTS;
ARTHROPLASTY, REPLACEMENT, HIP;
DISEASE MODELS, ANIMAL;
DOGS;
FACTOR XA;
FIBRINOGEN;
FIBRINOLYTIC AGENTS;
FOLLOW-UP STUDIES;
INJECTIONS, SUBCUTANEOUS;
NADROPARIN;
PARTIAL THROMBOPLASTIN TIME;
PLATELET COUNT;
PREMEDICATION;
PROTHROMBIN;
PULMONARY EMBOLISM;
THROMBOCYTOPENIA;
THROMBOPHLEBITIS;
|
|
EID: 0031304036
PISSN: 02314614
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
